Intrinsic Imaging Publishes its MCC Performance Targets Setting a New Standard In Medical Imaging Core Lab Efficiency

Share Article

Without compromising quality or regulatory compliance, Intrinsic Imaging is able to achieve unprecedented operational targets due to its unique technology, optimized business model and in depth radiology expertise.

Without compromising quality or regulatory compliance, we are able to achieve unprecedented operational targets due to our unique technology, our optimized business model and our in depth radiology expertise. said Todd A. Joron, BSc. MBA, President & COO

Intrinsic Imaging LLC, a bio/pharmaceutical medical imaging services organization publishes today its Metrics Champion Consortium (MCC) Imaging Performance Targets.

“Intrinsic Imaging’s business model is entirely focused on optimizing the management and analysis of medical images during Phase I-IV clinical trials. Without compromising quality or regulatory compliance, we are able to achieve unprecedented operational targets due to our unique technology, our optimized business model and our in depth radiology expertise across all therapeutic areas.” said Todd A. Joron, BSc, MBA, President and COO, Intrinsic Imaging.

Intrinsic Imaging is a corporate sponsor of the Metrics Champion Consortium (MCC). The MCC’s mission is to develop performance metrics within the biotechnology and pharmaceutical industry with the intent to jointly encourage performance improvement, effectiveness, efficiency, and appropriate levels of controls for both Sponsors and Service Providers in support of the drug development process. The MCC Imaging Performance Metrics Steering Committee recently released V1.0 of its imaging metrics.

“With our team of more than sixty sub-specialized, board-certified radiologists, and through use of our innovative Clinical Imaging Management System from Merge Healthcare, we are able to streamline our medical imaging operations.” said Todd Tibbetts, M.D., Ph.D., Medical Director, Oncology at Intrinsic. “We are thereby able to manage medical images much more effectively and provide radiology review of images to Sponsors in a much shorter time period.”

For comparative purposes, data presented within Table 1 identifies select operational targets related to imaging acquisition, processing, queries and submissions. As presented, Intrinsic Imaging’s target metrics are significantly more aggressive than current MCC targets. Table 1 may be viewed at http://www.intrinsiccro.com/IntrinsicMCC.html

Intrinsic executives attribute these material differences to their unique ability to readily implement new best-of-breed technologies to enable faster and more cost effective management, analysis and reporting of medical images in clinical trials.

Data presented within Table 2 provides a complete set of Intrinsic Imaging’s current operational targets. Intrinsic reports all of its MCC imaging metrics for each clinical trial and these are provided at no incremental cost to the Sponsor. Table 2 may be viewed at http://www.intrinsiccro.com/IntrinsicMCC.html

Further, to demonstrate the Company’s commitment to attaining these targets, Intrinsic Imaging provides all Sponsors with service level agreements (SLAs) identifying these metrics as appropriate.

About Intrinsic Imaging LLC
Located in San Antonio, Texas, Intrinsic is a bio/pharmaceutical services organization providing complete image management and radiological review services to global pharmaceutical, biotechnology and medical device organizations. With its team of more than sixty sub-specialized, board-certified radiologists, and through its use of advanced medical imaging technology, Intrinsic’s experienced clinical trial team provides pharmaceutical and biotech sponsors with comprehensive imaging core lab services across all therapeutic areas. For more information, please visit http://www.IntrinsicCRO.com

About The Metrics Champion Consortium (MCC)
The Metrics Champion Consortium (MCC) is an open, multidisciplinary, non-profit organization. The mission of MCC is to develop, through a collaborative process, performance metrics within the Biotechnology and Pharmaceutical industry with the intent to jointly encourage performance improvement, effectiveness, efficiency, and appropriate levels of controls for both Sponsors and Service Providers in support of the drug development process.

About Merge HealthCare
Merge Healthcare Incorporated develops and integrates information technology to create a better electronic healthcare experience. Merge products, ranging from standards-based development toolkits to sophisticated clinical applications, have been used by healthcare providers, vendors and researchers worldwide for over 20 years. Additional information can be found at http://www.merge.com/eclinical

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Todd Joron
Intrinsic Imaging
+1-888-492-9319 ext. 101
Email >
Visit website